Supraventricular TachycardiaNCT07148934
Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study
An observational study of Supraventricular Tachycardia and Atrial Fibrillation (AF), run by University of Turku at 1 site in Finland.
Trial summary
The aim of this study is to evaluate the reliability of smartphone seismocardiography (SCG) and bed-based ballistocardiography (BCG) for detecting supraventricular tachycardia (SVT) in children aged 0-10 years. The performance of these methods will be compared to the gold standard of continuous telemetry ECG recording. Read more about this study
- Who is it for?
- Ages 0 to 10 years
- Conditions the study is for
- Supraventricular Tachycardia, Atrial Fibrillation (AF)
- What is being tested?
- Smartphone seismographic recording and Bed Based Ballistocardiographic recordings
- How many people
- 60 participants
- Where
- 1 siteFinland
- Study dates
- Apr 2026to Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 10 years
- All sexes
- No healthy volunteers
- Child
Study population: N=up to 60, 30 for the study (SVT) group and 30 for the control group.
Who may be able to join
- For children in Study(SVT) group:
- received informed consent from both parents/guardians
- the child is treated in the Pediatric wards of Tyks Lighthouse hospital
- the child is between the age of 0-10 years
- the child has diagnosed or suspected SVT.
- For children in control group:
Show all 10Show fewer
- received informed consent from both parents/guardians
- the child is treated in the Pediatric wards of Tyks Lighthouse hospital
- the child is between the age of 0-10 years
- child has not diagnosed with SVT
Who cannot join
- All participant groups:
- not reaching the inclusion criteria
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Finland1 site
University of Turku
Turku, 20520
AJDAR ULLAH, (+358)404776970, ajulla@utu.fi
susanna Likitalo, susanna.m.likitalo@utu.fi
About this study
The aim of this study is to evaluate the reliability of smartphone seismocardiography (SCG) and bed-based ballistocardiography (BCG) for detecting supraventricular tachycardia (SVT) in children aged 0-10 years. The performance of these methods will be compared to the gold standard of continuous telemetry ECG recording.
Read the detailed description
This study aims to validate the use of a cardiac monitoring system, comprising a smartphone for seismocardiography (SCG) and a smart mattress for ballistocardiography (BCG), to detect supraventricular tachycardia (SVT) in children aged 0-10 years. Additionally, the study will compare heart rate and breathing rate measurements from these investigational devices against a Philips Intellivue X2 ECG Monitor, which serves as the gold standard. A convenience sample of up to 60 children (30 in the SVT group and 30 in the control group) will be recruited, and their parents will also be interviewed to explore their perceptions of arrhythmia monitoring. The primary objective is to develop and understand algorithms for differentiating SVT from sinus rhythm using SCG and BCG signals.
- Being tested
- Smartphone seismographic recording and Bed Based Ballistocardiographic recordings
- Keywords
- Supraventricular Tachycardia, Atrial Fibrillation, Seismocardiography, SmartPhone
- Medical subject headings
- Tachycardia, Supraventricular, Atrial Fibrillation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Smartphone seismographic recording and Bed Based Ballistocardiographic recordingsDiagnostic test
A short recording of heart rhythm using a smartphone and bed-based ballistocardiogram.
| Study group | Role | What they receive |
|---|---|---|
| Study( SVT) Group | Children aged 0-10 years treated in the pediatric wards of Tyks Lighthouse Hospital with diagnosed or suspected supraventricular tachycardia (SVT). Receives: Diagnostic Test: Smartphone seismographic recording and Bed Based Ballistocardiographic recordings | |
| Control Group | Children aged 0-10 years treated in the pediatric wards of Tyks Lighthouse hospital who have not been diagnosed with SVT (i.e., have a normal sinus rhythm). Receives: Diagnostic Test: Smartphone seismographic recording and Bed Based Ballistocardiographic recordings |
What is being measured
The primary outcome is the main question the study is designed to answer.
Algorithm development for Seismocardiograph and Ballistocardiograph for detecting Supraventricular tachycardia
Understanding and developing the algorithm to differentiate the supraventricular tachycardia (SVT) and sinus rhythm subjects based on seismocardiography and ballistocardiography signals.
Measured: 2025-2027
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2025
- Study startApr 2026 (estimated)
- Primary completionDec 2026 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Supraventricular TachycardiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Turku
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anna Axelin, University of Turku
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07148934
- Sponsor's protocol ID
- FIMEA/2025/002511-2
- Status last verified
- Apr 2026
- First submitted
- 22 Aug 2025
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study
- ClinicalTrials.gov ID
- NCT07148934
- Acronym / sponsor ID
- FIMEA/2025/002511-2
- Keywords
- Supraventricular Tachycardia, Atrial Fibrillation, Seismocardiography, SmartPhone
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of TurkuUniversity, hospital or other
- Study start
- Apr 2026 (estimated)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Jun 2027 (estimated)
- First posted
- 29 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to evaluate the reliability of smartphone seismocardiography (SCG) and bed-based ballistocardiography (BCG) for detecting supraventricular tachycardia (SVT) in children aged 0-10 years. The performance of these methods will be compared to the gold standard of continuous telemetry ECG recording.
Detailed description
This study aims to validate the use of a cardiac monitoring system, comprising a smartphone for seismocardiography (SCG) and a smart mattress for ballistocardiography (BCG), to detect supraventricular tachycardia (SVT) in children aged 0-10 years. Additionally, the study will compare heart rate and breathing rate measurements from these investigational devices against a Philips Intellivue X2 ECG Monitor, which serves as the gold standard. A convenience sample of up to 60 children (30 in the SVT group and 30 in the control group) will be recruited, and their parents will also be interviewed to explore their perceptions of arrhythmia monitoring. The primary objective is to develop and understand algorithms for differentiating SVT from sinus rhythm using SCG and BCG signals.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Study( SVT) Group | – | Diagnostic Test: Smartphone seismographic recording and Bed Based Ballistocardiographic recordingsChildren aged 0-10 years treated in the pediatric wards of Tyks Lighthouse Hospital with diagnosed or suspected supraventricular tachycardia (SVT). |
| Control Group | – | Diagnostic Test: Smartphone seismographic recording and Bed Based Ballistocardiographic recordingsChildren aged 0-10 years treated in the pediatric wards of Tyks Lighthouse hospital who have not been diagnosed with SVT (i.e., have a normal sinus rhythm). |
Who may qualify
- Ages
- 0 to 10 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- N=up to 60, 30 for the study (SVT) group and 30 for the control group.
Key inclusion criteria (10 listed)
- For children in Study(SVT) group:
- For children in control group:
Key exclusion criteria (2 listed)
- All participant groups:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Smartphone seismographic recording and Bed Based Ballistocardiographic recordingsA short recording of heart rhythm using a smartphone and bed-based ballistocardiogram. | Diagnostic test | Control Group, Study( SVT) Group |
Primary outcome
Algorithm development for Seismocardiograph and Ballistocardiograph for detecting Supraventricular tachycardia
Time frame: 2025-2027
Understanding and developing the algorithm to differentiate the supraventricular tachycardia (SVT) and sinus rhythm subjects based on seismocardiography and ballistocardiography signals.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Supraventricular Tachycardia
Not yet recruiting
Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in Japan
Atrial Fibrillation (AF), Atrial Flutter
Active, not recruitingPhase 1/2
Treatment of Orthostatic Intolerance
Tachycardia, Chronic Orthostatic Intolerance
RecruitingObservational study
AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)
Tachycardia, Paroxysmal Supraventricular Tachycardia
Not yet recruitingObservational study
Cardiac Arrhythmias in Pediatric Emergency Department
Arrhythmias, Cardiac, Tachycardia, Supraventricular
RecruitingObservational study
Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
Arrhythmias, Cardiac
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Supraventricular Tachycardia and Atrial Fibrillation (AF), run by University of Turku at 1 site in Finland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Algorithm development for Seismocardiograph and Ballistocardiograph for detecting Supraventricular tachycardia (time frame: 2025-2027). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.